It’s time for Bits & Bytes…
… where we bring you news, innovations, and thought-provoking insights from AI, IT, and beyond. In this week’s newsletter we’re looking at:
- AI predicts aging & cancer survival
- Saudi Arabia launches HUMAIN
- FDA goes full AI by June 30
IN THE SPOTLIGHT
✨ Google Launches AI Futures Fund to Back Startups
Google DeepMind has launched the AI Futures Fund an initiative backing startups with cutting-edge AI tools, cloud credits, and equity funding. Startups gain early access to models like Gemini, Imagen, and Veo, plus hands-on support from top Google experts.
Be it enhancing translation for digital comics or reimagining video creation, early participants are already building what was once impossible. Now, it’s your turn.
TL;DR
- Access Gemini, Imagen & Veo before public release.
- Collaborate directly with Google DeepMind & Labs teams.
- Get Google Cloud support + potential equity investment.
TECH HEADLINES FROM ACROSS THE WEB
🤖 KSA Launches HUMAIN to Lead in Arabic AI
Saudi Arabia has unveiled HUMAIN, a new state-backed AI company under its Public Investment Fund. With a focus on Arabic-language models and cross-sector AI adoption, HUMAIN marks a major step in the kingdom’s $100B AI push part of its broader Vision 2030 strategy to become a global AI leader.
🚀 FDA Fast-Tracks AI Across the Agency
The FDA just wrapped its first AI-assisted scientific review pilot and it’s already speeding things up. With full AI deployment across all centers by June 30, the agency is ditching tedious tasks to let scientists focus on what matters: faster, smarter drug approvals.
💡Carnegie Mellon Launches LegoGPT
LegoGPT is making headlines by turning text prompts into stable, buildable LEGO designs with impressive accuracy. This groundbreaking AI model generates detailed, physically stable models that can be assembled manually or by robots. With the release of the StableText2Lego dataset, LegoGPT is set to change the way we approach digital creation and design in the LEGO world.
TECH FOR GOOD
👵 AI Can Predict Aging & Cancer from Face!
FaceAge, a groundbreaking deep learning system, leverages facial photographs to estimate biological age, offering a more precise measure of a person’s health and prognosis than chronological age alone. Through extensive validation across multiple cancer cohorts, FaceAge demonstrated its significant potential in predicting survival outcomes, particularly for cancer patients undergoing palliative care.
By combining facial features with clinical data, this innovative tool not only enhances survival predictions but could also serve as a vital biomarker for aging, supporting physicians in making better-informed decisions for end-of-life care.
